An accomplished team of
innovative leaders

Josh Hexter joined Lifeward as Interim Chief Executive Officer in September 2026, bringing nearly two decades of leadership, business development and operational experience in the life science sector. Prior to Lifeward, Mr. Hexter held senior executive roles spanning general management, corporate development, in-licensing and commercial leadership across multiple healthcare sectors — including drug delivery, neuroscience, biopharmaceuticals and medical technology.

Mr. Hexter also serves as Chief Operating and Business Officer of Oramed Pharmaceuticals Inc. (Nasdaq: ORMP), and previously served as Chief Business Officer of BrainsWay Ltd. (NASDAQ/TASE: BWAY). Earlier in his career he was Executive Director of Corporate In-Licensing at BioLineRx (NASDAQ/TASE: BLRX), and worked in the private equity and venture capital sector, where he served as Chief Executive Officer of a venture-backed start-up.

Mr. Hexter has a bachelor’s degree from the University of Wisconsin and a master’s degree in management from Boston University.

Almog Adar joined the company in January 2020 and currently serves as Vice President of Finance. Almog served in several critical positions in the company’s finance department as a corporate controller and Director of Finance before joining the management team in 2022. Prior to joining Lifeward, Almog previously worked as Controller of Infinya Recycling Ltd (previously Amnir Recycling), from January 2018 until December 2019. From January 2016 until December 2017, Mr. Adar served as Assistant Controller of Delta Galil Industries. Mr. Adar has a Bachelor of Arts degree in Accounting and Economics from the Open University of Israel and is a Certified Public Accountant licensed by the Israeli Ministry of Justice.

Dr. Keith Rose joined Lifeward in March 2023 and currently serves as Chief Medical Officer. Keith served in several critical positions in the company’s clinical division as Medical Director and Vice President of Medical Affairs.

Prior to joining Lifeward, Keith worked as Medical Director, Medical Affairs and Director, Health Economics & Outcomes and Medical Effectiveness for Biocodex. In addition to his work at Biocodex, Dr. Rose has served as Lead Clinical Research Scientist and Regional Manager of Novocure, Inc.; Medical Director of Hope Network’s neurorehabilitation services for children and adults; Medical Director for multiple inpatient hospital rehabilitation centers; while he actively ran a private medical practice for 20+ years. 

Dr. Rose received his medical doctorate from the George Washington University School of Medicine and Health Sciences in Washington, DC and completed residencies in both Physical Medicine & Rehabilitation and Pediatric Medicine at the Baylor College of Medine in Houston, TX.

Miri Pariente joined the company in April 2013 and serves as Vice President of Quality Assurance, Regulatory and Operation. From 2012 to 2013, Ms. Pariente was the Manager of Quality Assurance at NLT Spine Ltd., a developer of minimally invasive spine procedures, and, from 2011 to 2012, was the Manager of Quality Assurance at ProAccess Medical Ltd. From 2002 to 2010, Ms. Pariente served in multiple roles within American Medical Systems including Production Supervisor and Lean Leader. Ms. Pariente holds a B.A. in business management from Derby University.

Craig Peters joined Lifeward in 2014 and currently serves as the Vice President of Sales, North America. Over the past eighteen years, he has been responsible for the commercialization of emerging technologies in the rehabilitation space.  

Before his transition into medical device sales, Craig spent five years specializing in the management of musculoskeletal disorders. He was responsible for the creation and direction of a fledgling start-up which grew into a multi-site physical therapy and personal training business in Milwaukee, WI. 

Mr. Peters is a graduate of Concordia University Wisconsin and holds a Doctor of Physical Therapy degree.

Mela Ikanovic is a seasoned executive in the medical device industry with close to two decades of international experience spanning market development, sales leadership, and operational management. Currently serving as Deputy General Manager and Vice President of International Sales at Lifeward GmbH, Mela has played a pivotal role in driving market access and strategic growth in Germany and across Europe. With a strong foundation in product launches and marketing, she has held leadership positions at Lifeward GmbH, Soteira GmbH, and Alitania GmbH. Mela began her career in journalism, holding roles at Deutsche Welle and as a freelance journalist, and holds a Master of Arts from Freie Universität Berlin.

David Hexner joined Lifeward in November of 2011 and currently serves as Vice President of Research and Development. David has played an integral role in the development of both the ReWalk Exoskeleton and the ReStore Exo-suit, beginning first in the role of Software and Algorithms Engineer, then that of Program Manager and finally of Director of Research and Development prior to joining the management team in 2021.

Mr. Hexner received his Bachelor’s degree in Electrical Engineering, as well as his Masters of Business Administration from the Technion-Israel Institute of Technology. Prior to joining Lifeward, David previously worked at Zoran Electronics which used to be a leading player in the semiconductor market which developed and sold chip sets for consumer electronics.

Ami Kraft joined the company in 2010. Mr. Kraft has been appointed as Executive Advisor to the CEO as of October 2017. Mr. Kraft previously served the company as President since August 2016, Senior Vice President from July 2015, and General Manager of ReWalk Robotics Ltd. in Israel since January 1, 2015. These positions are following his six-year tenure as our Chief Financial Officer, including the successful IPO in 2014. Before joining Lifeward, Mr. Kraft served as the Chief Financial Officer of various international technology companies, including PicScout, which was bought by Getty Images while he was serving as CFO, IC4IC, Zoran Corporation, where he was actively involved in their IPO, and Kulicke & Soffa Inc., where he served for over 20 years. Mr. Kraft holds a B.A. in public accounting from Haifa University and an MBA from Stanford University.